You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 28, 2024

Details for Patent: 8,109,918


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,109,918 protect, and when does it expire?

Patent 8,109,918 protects SINUVA and is included in one NDA.

This patent has six patent family members in five countries.

Summary for Patent: 8,109,918
Title:Sinus delivery of sustained release therapeutics
Abstract: The invention provides biodegradable implants for treating sinusitis. The biodegradable implants have a size, shape, density, viscosity, and/or mucoadhesiveness that prevents them from being substantially cleared by the mucociliary lining of the sinuses during the intended treatment period. The biodegradable implants include a sustained release therapeutic, e.g., an antibiotic, a steroidal anti-inflammatory agent, or both. The biodegradable implants may take various forms, such as rods, pellets, beads, strips, or microparticles, and may be delivered into a sinus in various pharmaceutically acceptable carriers.
Inventor(s): Eaton; Donald J. (Los Altos, CA), Moran; Mary L. (Woodside, CA), Brenneman; Rodney (San Juan Capistrano, CA)
Assignee: Intersect ENT, Inc. (Palo Alto, CA)
Application Number:12/479,794
Patent Claim Types:
see list of patent claims
Use; Delivery; Device;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 8,109,918: A Detailed Analysis

Introduction

United States Patent 8,109,918, like any other patent, is a complex document that outlines the scope and claims of an invention. To analyze this patent, it is crucial to understand the broader context of patent law, the specific claims made, and the implications of these claims within the patent landscape.

The Role of the USPTO

The U.S. Patent and Trademark Office (USPTO) is the agency responsible for granting U.S. patents and registering trademarks. The USPTO plays a critical role in evaluating the patentability of inventions, including the scope and claims of patents like 8,109,918[2].

Patent Scope and Claims

Patent scope refers to the breadth and depth of protection granted by a patent. It is often measured by metrics such as independent claim length and independent claim count. These metrics can indicate the complexity and breadth of the invention[3].

Independent Claim Length and Count

Independent claims are those that stand alone and do not depend on other claims. The length and count of these claims can provide insights into the patent's scope. Generally, narrower claims with fewer elements are more likely to be granted and have a shorter examination process compared to broader claims[3].

Claim Language and Structure

The language and structure of claims are vital in defining the scope of a patent. Claims must be clear, concise, and specific to avoid ambiguity and ensure enforceability. The USPTO's guidance updates, such as the 2024 update on AI patents, emphasize the importance of integrating judicial exceptions into practical applications to ensure patent eligibility[1].

Analyzing Patent 8,109,918

To analyze the scope and claims of Patent 8,109,918, one must delve into the patent document itself.

Claim Types

Patents typically include various types of claims:

  • Independent Claims: These define the invention broadly and are not dependent on other claims.
  • Dependent Claims: These are narrower and depend on the independent claims.
  • Method Claims: These describe the steps involved in the invention.
  • Apparatus Claims: These describe the physical components of the invention.

Claim Examples

For example, if Patent 8,109,918 involves a method for data processing, the independent claims might outline the general steps involved, while dependent claims might specify particular implementations or variations of these steps.

Practical Applications

The 2024 USPTO guidance update on AI patents highlights the importance of demonstrating practical applications to ensure patent eligibility. For instance, if a claim involves an abstract idea, it must be integrated into a practical application to be considered patent-eligible. This could involve specifying how the abstract idea is used to improve technology or solve a specific problem[1].

Patent Eligibility Criteria

Patent eligibility is determined by several criteria, including the integration of judicial exceptions into practical applications.

Judicial Exceptions

Judicial exceptions include abstract ideas, natural phenomena, and laws of nature. To be patent-eligible, claims must go beyond these exceptions by adding meaningful limits that transform the claim into a practical application.

Recent Case Law

The USPTO's guidance updates incorporate recent case law, ensuring that the application of patent eligibility criteria is consistent and reflects the latest judicial thinking. This helps in evaluating whether the claimed invention offers a concrete technological improvement[1].

Real-World Applications

Demonstrating real-world applications of the claimed method or system is crucial for bolstering the argument for patent eligibility. For example, if a claim involves an AI algorithm, specifying how this algorithm is used in a real-time speech recognition system to enhance accuracy can make the claim patent-eligible[1].

Search and Examination Process

The process of searching and examining patents involves several tools and resources provided by the USPTO.

Patent Public Search

The Patent Public Search tool allows users to search for existing patents and published patent applications. This tool is essential for conducting a preliminary patent search to ensure the novelty and non-obviousness of an invention[4].

Global Dossier

The Global Dossier service provides access to the file histories of related applications from participating IP Offices, helping users to see the patent family and related applications[4].

Implications for Innovators and Practitioners

Understanding the scope and claims of a patent like 8,109,918 is vital for innovators and practitioners.

Drafting Claims

Practitioners must draft claims that are likely to avoid section 101 rejections by ensuring that the claims integrate judicial exceptions into practical applications. The 2024 USPTO guidance update provides examples and detailed eligibility analysis to aid in this process[1].

Litigation and Licensing

The scope and claims of a patent can significantly impact litigation and licensing. Narrower claims with clear practical applications are generally more enforceable and less likely to face challenges in court[3].

Key Takeaways

  • Patent Scope Metrics: Independent claim length and count are important metrics for measuring patent scope.
  • Claim Language: Clear and specific claim language is crucial for defining the scope of a patent.
  • Practical Applications: Demonstrating practical applications is essential for ensuring patent eligibility.
  • Recent Case Law: Incorporating recent case law ensures consistency in the application of patent eligibility criteria.
  • Search and Examination: Utilizing tools like Patent Public Search and Global Dossier is vital for the patent examination process.

FAQs

What is the role of the USPTO in evaluating patent claims?

The USPTO is responsible for evaluating the patentability of inventions, including the scope and claims of patents, to ensure they meet the criteria for patent eligibility.

How do independent claim length and count affect patent scope?

Independent claim length and count can indicate the complexity and breadth of the invention. Narrower claims with fewer elements are generally more likely to be granted and have a shorter examination process.

What is the significance of integrating judicial exceptions into practical applications?

Integrating judicial exceptions into practical applications is crucial for ensuring patent eligibility. This involves adding meaningful limits to the claim that transform it into a practical application.

How does recent case law impact patent eligibility criteria?

Recent case law helps ensure consistency and clarity in the application of patent eligibility criteria, reflecting the latest judicial thinking.

What tools are available for searching and examining patents?

Tools such as the Patent Public Search, Global Dossier, and Patent and Trademark Resource Centers (PTRCs) are available for conducting thorough patent searches and examinations.

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent: Mintz, July 25, 2024.
  2. U.S. Patent and Trademark Office (USPTO) | USAGov: USA.gov.
  3. Patent Claims and Patent Scope: SSRN, September 29, 2016.
  4. Search for patents - USPTO: USPTO, October 18, 2018.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,109,918

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Intersect Ent Inc SINUVA mometasone furoate IMPLANT;IMPLANTATION 209310-001 Dec 8, 2017 RX Yes No 8,109,918 ⤷  Subscribe TREATMENT OF NASAL POLYPS IN PATIENTS >=18 YEARS OF AGE WHO HAVE HAD ETHMOID SINUS SURGERY USING A CORTICOSTEROID-ELUTING (MOMETASONE FUROATE) IMPLANT ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,109,918

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2004222340 ⤷  Subscribe
Canada 2518960 ⤷  Subscribe
European Patent Office 1605863 ⤷  Subscribe
European Patent Office 3103422 ⤷  Subscribe
Japan 2006520786 ⤷  Subscribe
World Intellectual Property Organization (WIPO) 2004082525 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.